ICU Background Early Awareness for Critical deterioratiON
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorETH Zurich
About this trial
The study will compare ICU sub-units, those with additional support of a clinician awareness system, ICU Beacon, and those receiving the standard of care. The win-ratio composite outcome will be assessed by comparing patients by study group and stratified by APACHE score at admission.
Eligibility criteria
Qualifiers
admission to intensive care unit
Disqualifiers
age < 18 years
presence of documented refused general consent form (at database closure)
admission for the sole purpose of dying/organ donation or evaluation of such
Trial design
Treatments tested in this trial
- ICU Beacon
Treatment groups
1,962 Participants
are divided into 2 treatment groupsSponsors and collaborators
ETH Zurich
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Collaborator
Source ClinicalTrials.gov